Transcription of JPMA Code of Practice
{{id}} {{{paragraph}}}
1 JPMA code of Practice (Established on January 16, 2013) (Enforced on April 1, 2013) (Revised on May 25, 2017) (Enforced on October 1, 2017) Japan Pharmaceutical Manufacturers Association (JPMA) [Preamble] Japan Pharmaceutical Manufacturers Association (JPMA) was established in 1968 as an organization of R&D-based pharmaceutical companies. The member companies of JPMA consider it their mission to contribute to improvements in the health and welfare of people in Japan and throughout the world through the development of safer, innovative, and highly useful pharmaceuticals. To support optimal medical care that is ethical and patient-oriented, JPMA calls upon member companies to build mutual relationships of trust with researchers, healthcare professionals, and patient organizations through appropriate industry-academia collaborations.
5 I-1. Code of Practice In keeping with the basic principles of the JPMA Code and in view of the fact that member companies engage in their corporate activities as members of the life sciences industry, which operates under the public medical insurance system,
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
The Singapore General Insurance Code of Practice, GENERAL INSURANCE, General Insurance Code of Practice, Insurance, INSURANCE IN SUPERANNUATION VOLUNTARY, Insurance in Superannuation Voluntary Code of Practice, Code, Motorhome Sales Code of Practice, Advertising Practice for Banks June2010, ADVERTISING PRACTICE FOR BANKS, Practice, PROFESSIONAL PRACTICE FOR ART THERAPISTS INTRODUCTION